Capromorelin Cats in Cats

Capromorelin is a prescription appetite stimulant used in cats, most commonly as the FDA-approved product Elura. In the United States, Elura is approved for management of weight loss in cats with chronic kidney disease, not as a general over-the-counter appetite booster. That distinction matters because weight loss in cats can be caused by many problems, including kidney disease, hyperthyroidism, dental pain, nausea, cancer, diabetes, and gastrointestinal disease. Your vet will usually want to identify the reason for poor appetite before deciding whether capromorelin fits the plan.

For many cats with chronic kidney disease, reduced appetite and gradual weight loss become major quality-of-life issues. Capromorelin can help some cats eat more consistently and regain or maintain body weight. It is not a cure for kidney disease, and it does not replace a full treatment plan. Cats taking capromorelin may still need nausea control, hydration support, diet changes, blood pressure treatment, phosphorus management, or other medications based on lab work and symptoms.

This medication is best viewed as one tool within a broader Spectrum of Care plan. Some pet parents use it short term during appetite dips. Others use it longer term with regular rechecks. The right approach depends on the cat’s diagnosis, body condition, hydration, blood glucose history, and how well the cat tolerates oral medication. Your vet may also compare capromorelin with other options, such as mirtazapine, anti-nausea medication, assisted feeding strategies, or a combination approach.

Capromorelin is a ghrelin receptor agonist. Ghrelin is a natural hormone involved in hunger signaling, energy balance, and growth hormone release. By mimicking ghrelin, capromorelin helps stimulate appetite and increases growth hormone activity. In cats with chronic kidney disease, that effect can translate into improved food intake and measurable weight gain over time.

The medication is given as an oral liquid. According to veterinary references, it usually starts working within a few hours, although the visible benefit can vary from cat to cat. Some cats show more interest in food the same day, while others need several days of consistent dosing before pet parents notice a meaningful change. Response also depends on whether appetite loss is driven mainly by hunger suppression, nausea, mouth pain, dehydration, or another untreated issue.

Capromorelin does more than trigger hunger. Because ghrelin receptors are found in multiple body systems, the drug can affect blood glucose, heart rate, gastrointestinal signs, and behavior in some cats. That is one reason your vet may recommend monitoring body weight, food intake, hydration, and lab values during treatment. If a cat is still not eating despite capromorelin, your vet may look for nausea, constipation, oral pain, worsening kidney disease, or another underlying problem rather than increasing treatment blindly.

The most commonly reported side effects in cats are vomiting and hypersalivation. Other reported effects include decreased appetite, behavior changes, lethargy, diarrhea, dehydration, urinary tract infection, and increased blood glucose. In the FDA field study for cats with chronic kidney disease, vomiting and hypersalivation were the most frequent adverse reactions. Some cats also had progression in kidney disease stage during the study, although these cats already had CKD and often had other health issues at the same time.

A practical point for pet parents is that mild drooling after dosing does not always mean a dangerous reaction. Oral liquids can taste unpleasant, and some cats foam or salivate briefly after administration. Still, repeated vomiting, marked lethargy, refusal to eat, weakness, or worsening thirst and urination deserve a call to your vet. Cats with a current or past history of diabetes need extra caution because capromorelin can raise blood glucose for several hours after dosing.

See your vet immediately if your cat collapses, has trouble breathing, seems severely weak, cannot keep water down, or stops eating entirely. Those signs may reflect the underlying disease, dehydration, or a medication problem. Your vet may decide to pause the drug, lower handling stress around dosing, add nausea control, or switch to another appetite support option.

Capromorelin for cats is typically given as Elura oral solution by mouth once daily. The labeled dose is 2 mg/kg, which equals 0.1 mL/kg of the 20 mg/mL solution. Your vet will calculate the exact amount based on your cat’s current body weight and may recheck that dose if your cat gains or loses weight. Because this is a prescription medication, pet parents should follow the label and their vet’s instructions rather than using a general online dose chart.

The bottle should be used with the provided dosing syringe so the amount is measured accurately. Many cats tolerate the medication best when it is given calmly and directly into the mouth, followed by a small food offering if your vet approves. If your cat spits out part of the dose, drools heavily, or fights dosing every day, tell your vet. Administration problems can affect how well the medication works and may change which option makes the most sense for your household.

If you miss a dose, contact your vet for guidance. In many cases, they will recommend giving it when remembered unless it is close to the next scheduled dose, but you should not double up unless your vet specifically tells you to. Regular monitoring matters. Your vet may ask you to track appetite, body weight, water intake, vomiting, and litter box habits so the plan can be adjusted early if needed.

Published veterinary references list several medications that may interact with capromorelin or require extra caution, including amiodarone, diltiazem, cimetidine, erythromycin, ketoconazole, itraconazole, rifampin, and phenobarbital. These drugs may affect how capromorelin is metabolized or how strongly it acts in the body. That does not always mean the combination is forbidden, but it does mean your vet should know about every prescription, supplement, and compounded medication your cat receives.

Cats with chronic kidney disease often take multiple medications at the same time, such as blood pressure drugs, anti-nausea medications, phosphate binders, potassium supplements, or thyroid treatment. In the FDA approval data, some enrolled cats were already receiving medications for conditions like hypertension and hyperthyroidism. That supports the real-world point that capromorelin is often used as part of a larger care plan, not in isolation.

There are also disease-state cautions. Elura should be avoided in cats with hypersomatotropism, also called acromegaly. Extra caution is advised in cats with liver disease because the drug is expected to be metabolized in the liver, and caution is also reasonable in cats with diabetes or a history of high blood glucose. If your cat’s appetite drops after starting a new medication, your vet may need to sort out whether the issue is the disease itself, nausea, a drug interaction, or poor tolerance of the dosing routine.